期刊文献+

迟发性运动障碍患者血清催乳素浓度研究 被引量:1

The serum concentration of prolactin in schizophrenic patients with tardive dyskinesia
原文传递
导出
摘要 目的了解伴迟发性运动障碍(TD)的慢性精神分裂症患者血清催乳素(PRL)浓度变化,探讨TD可能的病理机制。方法采用放射免疫法,对年龄、性别、服药相匹配的35例伴TD的慢性精神分裂症患者与35例不伴TD的慢性精神分裂症患者的血清催乳素浓度进行检测,比较两组间浓度差异,并对血清催乳素浓度与TD的严重程度进行相关分析。结果TD组血清PRL浓度显著高于非TD(P〈0.05)。TD严重程度与血清PRL浓度未呈现明显的相关性。结论TD患者存在血清PRL浓度升高,提示TD患者存在结节漏斗部DA神经原变性可能。
出处 《神经疾病与精神卫生》 2009年第6期527-528,共2页 Journal of Neuroscience and Mental Health
关键词 迟发性运动障碍 精神分裂症 催乳素 Tardive dyskinesia Schizophrenia Prolaetin
  • 相关文献

参考文献9

  • 1Soares--Weiser K,Fernandez HH. Tardive dyskinesia[J]. Semin Neurol, 2007,27(2) : 159-- 169.
  • 2詹亚茜.高催乳素血症的研究进展[J].华夏医学,2008,21(4):857-860. 被引量:3
  • 3Schooler NR,Kane JM. Research diagnoses for tardive dyskinesia[J]. Arch Gen Psychiatry, 1982,39(4) :486.
  • 4谢帆,王定省,宋立升,江开达.慢性精神分裂症住院病人迟发性运动障碍研究[J].中国神经精神疾病杂志,2002,28(1):27-29. 被引量:17
  • 5Correll CU,Schenk EM. Tardive dyskinesia and new antipsychotics[J]. Curr Opin Psychiatry, 2008,21(2):151--156.
  • 6Galili R, Mosberg, Gil-- Ad I, et al. Haloperidol-- induced neurotoxicity----possible implications for tardive dyskinesia[J]. J Neural Transm,2000,107(4) :479-490.
  • 7Singh A, Naidu PS,Kulkarni SK,et al. Possible antioxidant and neuroprotective mechanisms of FKS06 in attenuating haloperidol--induced orofacial dyskinesia[J]. Eur J Pharmaeol, 2003,477 (2) :87--94.
  • 8Bishnoi M,Chopra K,Kulkarni SK,et al. Possible anti--oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti- psychotic induced orofaeial dyskinesia : a biochemical and neurochemical study[J]. Prog Neuropsychopharmaeol Biol Psychiatry,2007,31(5):1 130--1 138.
  • 9谭云龙,周东丰,管振全,曹连元,邹义壮,苏建民.迟发性运动障碍患者血清泌乳素浓度分析[J].中国心理卫生杂志,2005,19(7):463-465. 被引量:3

二级参考文献32

共引文献19

同被引文献16

  • 1谭云龙,周东丰,管振全,曹连元,邹义壮,苏建民.迟发性运动障碍患者血清泌乳素浓度分析[J].中国心理卫生杂志,2005,19(7):463-465. 被引量:3
  • 2Dean C E,Thuras P D. Mortality and tardive dyskinesiaLong-term study using the US National Death Index[J]. Br J Psychiatry, 2009, 194(4) :360-364.
  • 3Tenback D E,van Harten P N,Slooff C J,et al. Incidence and persis- tence of tardive dyskinesia and extra- pyramidal symptoms in schizophrenia[J]. J Psychopharmacol, 2010,24 (7) : 1031-1035.
  • 4Guerreiro S, Ponceau A, Toulorge D, et al. Protection of mibrain dopaminergic neurons by the end product of purine metabolism uric acid: Potentiation by low level depolarization [J]. J Neurochem, 2009,109 (10) : 1118-1198.
  • 5Schooler N R, Kane J M. Research diagnoses for tardive dyskinesia [J]. Arch Gen Psychiatry, 1982,39 (4) t 486-487.
  • 6Nagatsu T, Sawada M. Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: Possible implications of glial cells['J]. J Neural Transm, 2006, (Suppl 71 ) : 53-65.
  • 7Jenner P. Oxidative stress in Parkinson's disease[J]: Ann Neurol, 2003,53(Suppl 3) :s26-36.
  • 8Andresen O A,Ferrante R J,Aamo T O,et al. Oral dyskinesias and histopathological alterations in substantia nigra after long--termhaloperidol treatment of old rats[-J]. Neuroseience, 2003,122 (3) : 717-725.
  • 9张文跃,顾凤华,谢立,韩晓东,宣春明.迟发性运动障碍与血清尿酸的关系[J].临床精神医学杂志,2008,18(2):107-108. 被引量:4
  • 10罗蔚锋,刘春风.尿酸水平与帕金森病[J].中华神经科杂志,2008,41(8):552-553. 被引量:16

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部